Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V. Chiarini
Efficacy of the New Long-Acting Formulation of Lanreotide (Lanreotide Autogel) in Somatostatin Analogue-Naive Patients With Acromegaly
Journal of Endocrinological Investigation
Endocrinology
Metabolism
Diabetes
Related publications
Effects of the Long-Acting Somatostatin Analogue Lanreotide Autogel on Glucose Tolerance and Insulin Resistance in Acromegaly
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Pharmacokinetic and Pharmacodynamic Properties of a Long-Acting Formulation of the New Somatostatin Analogue, Lanreotide, in Normal Healthy Volunteers.
British Journal of Clinical Pharmacology
Pharmacology
The Use of a Long-Acting Somatostatin Analogue (Lanreotide) in Three Children With Focal Forms of Congenital Hyperinsulinaemic Hypoglycaemia
Hormone Research in Paediatrics
Child Health
Endocrinology
Perinatology
Pediatrics
Metabolism
Diabetes
Glucose and Lipid Levels With Lanreotide Autogel 120 Mg in Treatment-Naïve Patients With Acromegaly: Data From the PRIMARYS Study
Clinical Endocrinology
Endocrinology
Metabolism
Diabetes
Population Pharmacokinetic Analysis of Lanreotide Autogel® in Healthy Subjects
Clinical Pharmacokinetics
Pharmacology
Effectiveness and Tolerability of Lanreotide in Acromegaly: A German Database Analysis
Endocrine Abstracts
Treatment of Patients With Pancreatic Endocrine Tumours Using a New Long-Acting Somatostatin Analogue Symptomatic and Peptide Responses.
Gut
Gastroenterology
A Comparison Between Octreotide-Lar and Lanreotide-Sr in the Chronic Treatment of Acromegaly
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Differing Effects on Gall-Bladder Motility of Lanreotide SR and Octreotide LAR for Treatment of Acromegaly
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
